0.0040
0.0000
(0.00%)
At close: January 30 at 3:00:00 PM EST
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-66.4440
-8.5160
-312.6630
-293.3930
-251.3270
Financing Cash Flow
65.6150
44.1390
341.1780
290.0000
215.5000
End Cash Position
1.3920
74.9860
39.3630
10.8480
14.2410
Issuance of Debt
98.0000
110.0000
410.0000
290.0000
215.5000
Repayment of Debt
-32.3850
-65.8610
-68.8220
--
--
Free Cash Flow
-66.4440
-8.5160
-312.6630
-293.3930
-251.3270
9/30/2020 - 2/24/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTH Arch Therapeutics, Inc.
0.1810
0.00%
ELOX Eloxx Pharmaceuticals, Inc.
0.0001
0.00%
RGBP Regen BioPharma, Inc.
0.0621
0.00%
CELC Celcuity Inc.
11.95
+1.96%
ADXS Ayala Pharmaceuticals, Inc.
0.0286
0.00%
PLRX Pliant Therapeutics, Inc.
10.75
+0.84%
PRAX Praxis Precision Medicines, Inc.
76.55
+0.46%
LRMR Larimar Therapeutics, Inc.
3.8400
-3.27%
IMVT Immunovant, Inc.
21.74
-1.50%
ADAP Adaptimmune Therapeutics plc
0.5900
-3.12%